Adverse drug reactions in clinical practice – clinical and economic aspects

Kliknij autora aby wyszukać wszystkie publikowane przez niego artykuły:
Mateusz Maciejczyk, Edyta Rysiak, Halina Car

4 (49) 2016 s. 411–414
Click to return to issue contents
411_4_49_2016.pdf
Digital version of article (in PDF file)

DOI: https://doi.org/10.20883/ppnoz.2016.29

Fraza do cytowania: Maciejczyk M., Rysiak E., Car H. Adverse drug reactions in clinical practice – clinical and economic aspects. Polski Przegląd Nauk o Zdrowiu. 2016;4(49):411–414. DOI: https://doi.org/10.20883/ppnoz.2016.29

Adverse drug reactions are an important and increasingly frequent problems in clinical practice. This term describes all the unintended and adverse effects of drugs, which occur as a result of the use of appropriate doses of drugs for the prevention, diagnosis, treatment, as well as to modification the physiological function of the body. Especially dangerous for the patient are severe side effects that can lead to life-threatening, persistent or significant prejudice to health, as well as death. Adverse drug reactions monitoring enables the assessment of the potential risks and expected benefits associated with the use of medicinal products. These activities may increase the effectiveness of drug treatment and lead to a significant reduction in financial resources allocated to pharmacotherapy. The aim of the study is to assess the adverse drug reactions in clinical and pharmacoeconomics aspects.

Key words: side effects of drugs, adverse drug reactions monitoring, pharmacoeconomics.



Copyright © 1989–2019 Polish Review of Health Sciences. All rights reserved.